Patents by Inventor Gary Patrick Sims

Gary Patrick Sims has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Binding molecules specific for Fc?RIIA and uses thereof
    Patent number: 11746153
    Abstract: The disclosure provides Fc?RIIA-binding molecules, for example, humanized monoclonal antibodies capable of inhibiting Fc?RIIA activity, and methods of using the Fc?RIIA binding molecules, for example, in treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: September 5, 2023
    Assignee: Viela Bio, Inc.
    Inventors: Katherine Ann Vousden, Bo Chen, Gary Patrick Sims
  • BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF
    Publication number: 20220380458
    Abstract: The disclosure provides Fc?RIIA-binding molecules, for example, humanized monoclonal antibodies capable of inhibiting Fc?RIIA activity, and methods of using the Fc?RIIA binding molecules, for example, in treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders.
    Type: Application
    Filed: March 1, 2022
    Publication date: December 1, 2022
    Applicant: VIELA BIO, INC.
    Inventors: Katherine Ann Vousden, Bo Chen, Gary Patrick Sims
  • Binding molecules specific for Fc?RIIA and uses thereof
    Patent number: 11306145
    Abstract: The disclosure provides Fc?RIIA-binding molecules, for example, humanized monoclonal antibodies capable of inhibiting Fc?RIIA activity, and methods of using the Fc?RIIA binding molecules, for example, in treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: April 19, 2022
    Assignee: Viela Bio, Inc.
    Inventors: Katherine Ann Vousden, Bo Chen, Gary Patrick Sims
  • BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF
    Publication number: 20200002415
    Abstract: The disclosure provides Fc?RIIA-binding molecules, for example, humanized monoclonal antibodies capable of inhibiting Fc?RIIA activity, and methods of using the Fc?RIIA binding molecules, for example, in treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders.
    Type: Application
    Filed: April 28, 2017
    Publication date: January 2, 2020
    Applicant: Viela Bio, Inc.
    Inventors: Katherine Ann Vousden, Bo Chen, Gary Patrick Sims